We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 22 MARCH 2016
PTAB Institutes Kyle Bass IPR Against Pharmaceutical Patent Based On SEC Document
Foley & Lardner LLP
Kyle Bass has filed numerous prior IPR petitions against pharmaceutical patents, some of which have been denied due to use of prior art references that were not sufficiently proven to be "publicly accessible".
United StatesIntellectual Property







